Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. Cultivation outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. Canada Legal Cannabis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Canada Legal Cannabis: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Regulatory Framework
Chapter 4. Canada Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Canada Legal Cannabis market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Flowers
4.5.2.1. Flowers market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Hemp
4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Canada Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Derivatives Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Canada Legal Cannabis market, by Derivatives, 2018 to 2030
5.5. CBD
5.5.1. CBD market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. THC
5.6.1. THC market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Other derivatives
5.7.1. Other derivatives market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Canada Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. Canada Legal Cannabis market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Canada Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2023 & 2030
7.3. Segment Dashboard
7.4. Global Canada Legal Cannabis Market, by End Use, 2018 to 2030
7.5. Medical Use
7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Cancer
7.5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Chronic Pain
7.5.3.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Depression and Anxiety
7.5.4.1. Depression and Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Arthritis
7.5.5.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Diabetes
7.5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Glaucoma
7.5.7.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Migraine
7.5.8.1. Migraine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Epilepsy
7.5.9.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. AIDS
7.5.11.1. AIDS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Amyotrophic Lateral Sclerosis
7.5.12.1. Amyotrophic Lateral Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Alzheimer’s
7.5.13.1. Alzheimer’s Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Post Traumatic Stress Disorder (PTSD)
7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.15. Parkinson's
7.5.15.1. Parkinson's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.16. Tourette’s
7.5.16.1. Tourette’s Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.17. Others
7.5.17.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Recreational Use
7.6.1. Recreational Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Industrial Use
7.7.1. Industrial Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Canopy Growth Corporation
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Charlotte's Web, Inc.
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Aurora Cannabis Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Tilray Brands
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. The Cronos Group
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Jazz Pharmaceuticals, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Sundial Growers
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Organigram Holding, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Maricann, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Isodiol International, Inc
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Canada legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Canada legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 Canada legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 6 Canada legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Canada legal cannabis market: outlook
Fig. 9 Canada legal cannabis competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 Canada legal cannabis market driver impact
Fig. 12 Canada legal cannabis market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 Canada legal cannabis market: Source movement analysis
Fig. 16 Canada legal cannabis market: Source outlook and key takeaways
Fig. 17 Marijuana market estimates and forecast, 2018 - 2030
Fig. 18 Flowers market estimates and forecast, 2018 - 2030
Fig. 19 Oil and Tinctures market estimates and forecast, 2018 - 2030
Fig. 20 Hemp market estimates and forecast, 2018 - 2030
Fig. 21 Hemp Oil market estimates and forecast, 2018 - 2030
Fig. 22 Industrial Hemp market estimates and forecast, 2018 - 2030
Fig. 23 Canada legal cannabis market: Derivatives movement analysis
Fig. 24 Canada legal cannabis market: Derivatives outlook and key takeaways
Fig. 25 CBD market estimates and forecasts, 2018 - 2030
Fig. 26 THC market estimates and forecasts, 2018 - 2030
Fig. 27 Other derivatives market estimates and forecasts, 2018 - 2030
Fig. 28 Canada legal cannabis market: Cultivation movement analysis
Fig. 29 Canada legal cannabis market: Cultivation outlook and key takeaways
Fig. 30 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 31 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 Canada legal cannabis market: End Use movement analysis
Fig. 34 Canada legal cannabis market: End Use outlook and key takeaways
Fig. 35 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 36 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 37 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 38 Post - Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 39 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 40 Migraines market estimates and forecasts, 2018 - 2030
Fig. 41 Cancer market estimates and forecasts, 2018 - 2030
Fig. 42 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 43 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 44 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 47 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 48 AIDS market estimates and forecasts, 2018 - 2030
Fig. 49 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 50 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 52 Others market estimates and forecasts, 2018 - 2030
Fig. 53 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 54 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 55 Key company categorization
Fig. 56 Heat map analysis - 2023